E. Blair Clark-Schoeb

E. Blair Clark-Schoeb currently serves as Principal at BiotechComm since September 2024, having previously held the position of Chief Communications Officer at Lykos Therapeutics from September 2022 to September 2024. With a career spanning over two decades, E. Blair Clark-Schoeb has held significant roles including Senior Vice President of Communications at Aruvant and Zyla Life Sciences, as well as Owner of BiotechComm during two separate periods. Earlier experience includes positions at WeissComm Partners and Burns McClellan, focusing on public relations and investor relations within the biotech and healthcare sectors. E. Blair Clark-Schoeb holds a Master of Healthcare Innovation from the University of Pennsylvania and has an educational background from Harvard University.